SURVEILLANCE OF UPPER URINARY TRACT TRANSITIONAL CELL CARCINOMA: : THE ROLE OF URETEROSCOPY, RETROGRADE PYELOGRAPHY, CYTOLOGY AND URINALYSIS

2000 ◽  
Vol 164 (6) ◽  
pp. 1901-1904 ◽  
Author(s):  
Gregory L. Chen ◽  
Ehab A. El-Gabry ◽  
Demetrius H. Bagley
Urology ◽  
1991 ◽  
Vol 37 (4) ◽  
pp. 331-336 ◽  
Author(s):  
Brian Guz ◽  
Stevan B. Streem ◽  
Andrew C. Novick ◽  
James E. Montie ◽  
Margaret G. Zelch ◽  
...  

1997 ◽  
pp. 1622-1624 ◽  
Author(s):  
Hideki Komatsu ◽  
Nobuaki Tanabe ◽  
Satoshi Kubodera ◽  
Hiroaki Maezawa ◽  
Akira Ueno

1996 ◽  
Vol 63 (1) ◽  
pp. 25-28
Author(s):  
S. Cosciani Cunico ◽  
E. Frego ◽  
M. Scanzi ◽  
T. Zanotelli ◽  
E. Panizza ◽  
...  

— The incidence of upper urinary tract transitional cell carcinoma (UTTCC) following a bladder cancer has been studied in 1731 urothelial tumours from 1984 to 1995. The UTTCC were 88: 59 primitive, 6 synchronous and 23 metachronous after a bladder cancer (1672). Of the 23 metachronous UTTCC, 17 followed TURBT (17/1310 = 1.3%): the latency period was very long (64.8 months); grading and staging were mostly similar to the foregoing bladder tumours. A vesicoureteral reflux raised the metachronous UTTCC rate to 17.6%. A neoplastic distal ureter was found during radical cystectomy in 2.24%. During the follow-up of 362 radical cystectomies 6 (1.65%) metachronous UTTCC were recorded. A metachronous UTTCC is always a poor prognostic sign. There are some controversies concerning this topic such as: the role of IVP and urine cytology in the follow-up of bladder cancer, the management of a vesicoureteral reflux in bladder cancer and the choice of a urinary diversion in the event of an upper urinary tract at high risk for UTTCC.


1997 ◽  
Vol 157 (5) ◽  
pp. 1622-1624 ◽  
Author(s):  
Hideki Komatsu ◽  
Nobuaki Tanabe ◽  
Satoshi Kubodera ◽  
Hiroaki Maezawa ◽  
Akira Ueno

Sign in / Sign up

Export Citation Format

Share Document